ophthalmologytimes6 小时
ACELYRIN announces phase 2b/3 trial of izokibep did not meet primary endpoint, ceases ...
The phase 2b/3 clinical trial (NCT05683496) evaluated izokibep versus placebo in non-infectious, non-anterior uveitis.